Cargando…

Know thy cells: commonly used triple-negative human breast cancer cell lines carry mutations in RAS and effectors

Detalles Bibliográficos
Autor principal:	Wagner, Kay-Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238191/ https://www.ncbi.nlm.nih.gov/pubmed/35761335 http://dx.doi.org/10.1186/s13058-022-01538-8

Ejemplares similares

Know Thy Ulcers!!!
por: Govil, Deepak, et al.
Publicado: (2020)

Genomes of model organisms: know thy tools
por: Galperin, Michael Y
Publicado: (2008)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Thy-1+ and Thy-1- natural killer cells. Only Thy-1- natural killer cells suppress dendritic cells
Publicado: (1986)

Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors
por: Zhang, Lilong, et al.
Publicado: (2022)

RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018)

Carrying Stethoscopes
por: Chatterjee, R. N.
Publicado: (1948)

Know Thy Neighbor: Costly Information Can Hurt Cooperation in Dynamic Networks
por: Antonioni, Alberto, et al.
Publicado: (2014)

Know Thy Selves: Learning to Understand Oneself Increases the Ability to Understand Others
por: Böckler, Anne, et al.
Publicado: (2017)

Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
por: Altundag, Kadri
Publicado: (2023)

Know thy neighbors: The status of cardiac surgery in the South Asian countries around India
por: Hosain, Nazmul, et al.
Publicado: (2017)

Targeting a cell state common to triple-negative breast cancers
por: Muellner, Markus K, et al.
Publicado: (2015)

The Range of the Malaria-Carrying Mosquito
por: Napier, L. Everard
Publicado: (1940)

Can Flies Carry Cholera?
por: Donovan, Hugh L.
Publicado: (1886)

He Wants to Know
por: Parker, N.
Publicado: (1921)

Beyond differential expression: the quest for causal mutations and effector molecules
por: Hudson, Nicholas J, et al.
Publicado: (2012)

Phytate Intake, Health and Disease: “Let Thy Food Be Thy Medicine and Medicine Be Thy Food”
por: Pujol, Antelm, et al.
Publicado: (2023)

Let food be thy medicine and medicine be thy food?
por: Stauss, Madelena, et al.
Publicado: (2018)

A commentary on ‘Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery’
por: Li, Jialin, et al.
Publicado: (2023)

The Ins and Outs of RAS Effector Complexes
por: Kiel, Christina, et al.
Publicado: (2021)

Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
por: Saw, Jacqui-Lyn, et al.
Publicado: (2022)

AML cells carrying NPM1 mutation are resistant to nucleophosmin displacement from nucleoli caused by the G-quadruplex ligand TmPyP4
por: De Cola, A, et al.
Publicado: (2014)

Cyr61 as mediator of Src signaling in triple negative breast cancer cells
por: Sánchez-Bailón, María Pilar, et al.
Publicado: (2015)

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2022)

PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
por: Zha, Hualian, et al.
Publicado: (2022)

“Query.”—What We Want to Know
Publicado: (1896)

The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions
por: Nakhaeizadeh, Hossein, et al.
Publicado: (2016)

Thy-1 Is a Component Common to Multiple Populations of Synaptic Vesicles
por: Jeng, Chung-Jiuan, et al.
Publicado: (1998)

Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors
por: Markkanen, Enni
Publicado: (2019)

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
por: Altundag, Kadri
Publicado: (2017)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
por: Boucher, Yves, et al.
Publicado: (2021)

Normal B cell development and Pax5 expression in Thy28/ThyN1-deficient mice
por: Kitaura, Fusako, et al.
Publicado: (2019)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation
por: Vandal, Guillaume, et al.
Publicado: (2014)

Penile Pyoderma Gangrenosum: A Mimicker to Know
por: Mehdi, Khallaayoune, et al.
Publicado: (2021)

Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes
por: Tritto, Viviana, et al.
Publicado: (2023)

Mycoplasma pneumoniae–Specific IFN-γ–Producing CD4(+) Effector-Memory T Cells Correlate with Pulmonary Disease
por: Pánisová, Elena, et al.
Publicado: (2021)

Opposing regulatory functions of the TIM3 (HAVCR2) signalosome in primary effector T cells as revealed by quantitative interactomics
por: Zhai, Yunhao, et al.
Publicado: (2020)

Win Thy Heart
por: Das, Mrinal Kanti
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4cem3hn3gag44aqndoqc53ml81